Your browser doesn't support javascript.
loading
Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
Ni, Feng; Yan, Chang-You; Zhou, Sheng; Hui, Peng-Yu; Du, Yong-Hui; Zheng, Liang; Yu, Jin; Hu, Xiao-Jian; Zhang, Zhi-Gang.
Afiliação
  • Ni F; Department of Urology, The 2nd Affiliated Hospital of Xi'an Medical University, Xi'an, 710038, Shaanxi Province, China.
  • Yan CY; Family Planning Service Stations of Health and Family Planning Commission of Chengcheng County, Chengcheng County, Weinan City, 714000, Shaanxi Province, China.
  • Zhou S; Department of Anorectal Surgery, The 2nd Affiliated Hospital of Xi'an Medical University, No. 167 Fangdong Street, Baqiao District, Xi'an, 710038, Shaanxi Province, China. 997196691@qq.com.
  • Hui PY; Department of Urology, The 2nd Affiliated Hospital of Xi'an Medical University, Xi'an, 710038, Shaanxi Province, China.
  • Du YH; Department of Urology, The 2nd Affiliated Hospital of Xi'an Medical University, Xi'an, 710038, Shaanxi Province, China.
  • Zheng L; Department of Urology, The 2nd Affiliated Hospital of Xi'an Medical University, Xi'an, 710038, Shaanxi Province, China.
  • Yu J; Department of Urology, The 2nd Affiliated Hospital of Xi'an Medical University, Xi'an, 710038, Shaanxi Province, China.
  • Hu XJ; Department of Urology, The 2nd Affiliated Hospital of Xi'an Medical University, Xi'an, 710038, Shaanxi Province, China.
  • Zhang ZG; Department of Urology, The 2nd Affiliated Hospital of Xi'an Medical University, Xi'an, 710038, Shaanxi Province, China.
Cancer Chemother Pharmacol ; 82(4): 593-605, 2018 10.
Article em En | MEDLINE | ID: mdl-30032449
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Cisplatino / Resistencia a Medicamentos Antineoplásicos / Proteína bcl-X / NADH NADPH Oxirredutases Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Cisplatino / Resistencia a Medicamentos Antineoplásicos / Proteína bcl-X / NADH NADPH Oxirredutases Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha